NCT00111878View on ClinicalTrials.gov

Study to Evaluate MEDI-534 in Healthy Adults

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

December 31, 2005

Conditions
Respiratory Syncytial Virus InfectionsParainfluenza Infections
Interventions
DRUG

MEDI-534

Trial Locations (3)

15241

Primary Physicians Research, Pittsburgh

43205

Children's Hospital, Columbus

75247

Radiant Research, Dallas

Sponsors

Lead Sponsor

MedImmune LLC
All Listed Sponsors
lead

MedImmune LLC

INDUSTRY